Penn Today Online

Related Links
Find a Specialist
Make a Referral Online or call 1-800-789-PENN
Patient Education Articles
 

 


 Penn Today Online

Current Issue
Bloodless Robotic Surgery for Gynecologic Cancers
Good Shepherd Rehabilitation Network & Penn Medicine: Partners in Post-Acute Care
Importance of Evaluation for Obstructive Sleep Apnea in Obese Patients with Type 2 Diabetes
Physician Announcements
Archive of Articles
 
Subscribe to the Newsletter
Newsletter RSS Feed RSS feed
   

Home
Penn Today Online
Referral Directory
Physician Tools
Urgent Patient Transfer
Research
Upcoming CMEs

Importance of Evaluation for Obstructive Sleep Apnea in Obese Patients with Type 2 Diabetes

September / October 2009

Specialists at the Penn Sleep Centers are encouraging physicians treating obese patients with diabetes, particularly those with higher waist circumferences (truncal obesity), to be evaluated for obstructive sleep apnea (OSA). Data from epidemiologic and clinical studies now suggests that OSA places patients at increased risk for the development of altered glucose metabolism, and could thus be a contributing cause of type 2 diabetes.1 In studies comparing obese OSA patients with weight-matched non-OSA controls, the combination of OSA and obesity was found to increase insulin resistance.2

According to a recent report,3 the prevalence of undiagnosed OSA among obese patients with type 2 diabetes is greater than 85% (Figure 1). Importantly, many of the patients in the study had no symptoms of sleepiness or snoring, and reported symptoms (such as sleepiness and snoring) did not predict which patients were likely to have sleep apnea. More than half of the patients with OSA had moderate or severe sleep apnea, a factor shown in recent population-based as well as longitudinal studies to be an independent risk factor for all-cause mortality.

Some studies4,5 have shown that diabetic patients with OSA who receive sustained, regular treatment with continuous positive airway pressure (CPAP) can improve insulin sensitivity and glycaemic control. CPAP treatment has been demonstrated to reduce systolic blood pressure and heart rate and to improve left ventricular ejection fraction in patients with OSA.

Figure 1. Undiagnosed OSA occurs in more than 85% of diabetic patients with obesity.

Case Study
Mr. E, a 35-year-old man, presented to his primary care physician for routine follow-up care. His medical history was significant for type 2 diabetes, hypertension and obesity. Outpatient medications included metformin 1000mg twice daily, lisinopril 10mg once daily and amlodipine 10mg once daily. The patient had no specific complaints during the visit but, when asked by his physician, admitted that his wife had urged him to visit because she could no longer tolerate his snoring. He denied excessive daytime sleepiness. Clinical examination was significant only for obesity (body mass index = 37.2kg/m2) and an elevated blood pressure of 145/94, despite antihypertensive medications.

An outpatient sleep study was ordered to investigate for obstructive sleep apnea (OSA). The polysomnogram revealed severe obstructive sleep apnea with an apnea hypopnea index of 42 events per hour and an oxyhemoglobin nadir of 80%. The patient was referred for a titration polysomnogram, which established a CPAP pressure of 10 cm of water as the optimal pressure needed to treat Mr. E's severe OSA. CPAP therapy was initiated using a nasal mask interface.

Mr. E returned to his primary care provider three months later. His blood pressure was within optimal range (128/74) without change in his antihypertensive regimen. His wife reported his snoring had been abolished with the use of his CPAP unit. In addition, Mr. E noted that he now feels more energized and rested on waking in the morning.

"Given that OSA may complicate diabetes in the obese, it's important that physicians treating obese patients with type 2 diabetes consider the possibility of OSA, even in the absence of symptoms. This is especially true of those with higher waist circumference and higher BMI levels."

Allan I. Pack, MB, ChB, PhD
Chief, Division of Sleep Medicine
Professor of Medicine

References

  1. Tasali E, Mokhlesi B, Van Cauter E. Chest. 2008;133:496-506.
  2. Tassone F, Lanfranco F, Gianotti L, et al. Clin Endocrinol (Oxf). 2003;59:374-379.
  3. Foster GD, Sanders MH, Millman R, et al. In press. Diabetes Care. 2009.
  4. Schachin SP, Nechanitzky T, Dittel C, et al. Med Sci Monit. 2008;14: CR117-CR121.
  5. Harsch IA, Schahin SP, Radespiel-Tröger M, et al. Am J Resp Crit Care Med. 2004;169:156-162.

Our Team of Faculty
The Penn Sleep Center is comprised of a multidisciplinary team of clinicians from the departments of medicine, neurology, psychiatry, otorhinolaryngology and oral and maxillofacial surgery-a concentration of expertise that permits a comprehensive approach to the diagnosis and treatment of sleep disorders and their comorbidities. One of only three sleep centers in the United States designated by the National Institutes of Health as a specialized center for research in sleep, the Penn Sleep Center is fully accredited by the American Academy of Sleep Medicine. With seven locations in the Philadelphia area, the Sleep Center currently performs more than 5,000 sleep studies each year.

Allan I. Pack, MB, ChB, PhD
Chief, Division of Sleep Medicine
Professor of Medicine

Charles R. Cantor, MD, DABSM
Medical Director, Penn Sleep Centers
Clinical Associate Professor of Neurology

Maria Antoniou, MD, DABSM
Assistant Professor of Clinical Medicine

Eliot Friedman, MD
Instructor in Medicine

Philip Gehrman, PhD, CBSM
Assistant Professor of Psychiatry

Nalaka S. Gooneratne, MD, DABSM
Assistant Professor of Medicine

Indira Gurubhagavatula, MD, MPH
Assistant Professor of Medicine

Nirav Patel, MD
Assistant Professor of Clinical Medicine

Grace W. Pien, MD, MSCE, DABSM
Assistant Professor of Medicine

David M. Raizen, MD, PhD, DABSM
Assistant Professor of Neurology

Ilene M. Rosen, MD, MSCE, DABSM
Assistant Professor of Clinical Medicine

Sharon L. Schutte-Rodin, MD, DABSMD
Clinical Associate Professor of Medicine

Richard J. Schwab, MD, DABSM
Professor of Medicine

Sigrid C. Veasey, MD, DABSM
Associate Professor of Medicine

Mark Wu, MD, PhD
Instructor in Neurology

Access
Patient appointments are available at:

Penn Sleep Center
Hospital of the University of Pennsylvania***~
11th Floor, Gates Building
3400 Spruce Street
Philadelphia, PA 19104

Penn Sleep Center*~
3624 Market Street, Suite 201
Philadelphia, PA 19104
Pennsylvania Hospital*
800 Spruce Street
Philadelphia, PA 19107

Penn Medicine at Radnor**~
250 King of Prussia Road
2nd Floor
Radnor, PA, 19087

Penn Sleep Center at the Sheraton University City Hotel***~
36th & Chestnut Streets
Philadelphia, PA 19104

Penn Sleep Center at the Pavilion at Doyestown Hospital***
599 West State Street, Suite 101
Doylestown, PA 18901

Penn Sleep Center at the Hilton Homewood Suites***~
681 Shannondell Blvd.
Audubon, PA 19403

~ A facility of the Hospital of the University of Pennsylvania
* Indicates overnight sleep study site and sleep specialist site
** Indicates sleep specialist site
*** Indicates overnight sleep study site

To refer a patient and/or consult with a doctor: Call 800-789-PENN (7366) or refer a patient online.


Referring Physicians: To speak with a Penn physician or refer a patient, contact PennHealth through the secure online referral form or by calling
1-800-789-PENN (7366).

   
   

 

About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2010, The Trustees of the University of Pennsylvania space